- Home
- PDC vs CRIS Comparison
PDC vs CRIS Comparison
Compare PDC & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PDC | CRIS |
|---|---|---|
| Founded | 2018 | 2000 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 14.0M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | PDC | CRIS |
|---|---|---|
| Price | $4.82 | $1.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 28.6K | ★ 148.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $3.46 | $0.77 |
| 52 Week High | $7.80 | $3.18 |
Technical Indicators
Market Signals| Indicator | PDC | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 45.91 | 49.32 |
| Support Level | $4.29 | $0.80 |
| Resistance Level | $5.64 | $1.04 |
| Average True Range (ATR) | 0.51 | 0.08 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 36.52 | 37.21 |
Price Performance
Historical ComparisonAbout PDC Perpetuals.com Ltd American Depositary Shares
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.